Humira(CF) pen 40 MG/0.4 MLS
Ended Awarded
- Contract number
- SPE2DB25FE4J8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,701
Award facts
- Contract value 100% obligated
- $23,700.82 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $23,700.82 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of HUMIRA (adalimumab) CF Pen 40 mg/0.4 mL auto-injectors. This is a non-set-aside contract with an ultimate completion date of September 4, 2025, with performance occurring at the contractor's Conshohocken, Pennsylvania facility. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement through its extensive portfolio of competitively awarded contracts with the Defense Logistics Agency and its Medical Supply Chain. The company's federal contracting history demonstrates versatility in fulfilling diverse military healthcare supply requirements, including specialty medications, brand-name and generic pharmaceuticals, and medical devices across multiple therapeutic domains. This delivery order supports the Defense Health Agency and other government healthcare systems' ongoing pharmaceutical needs through the flexible framework of the DLA's comprehensive pharmaceutical prime vendor program.
Quick answers
Who was awarded contract SPE2DB25FE4J8?
SPE2DB25FE4J8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 3, 2025.
How much is contract SPE2DB25FE4J8 worth?
The government has obligated $23,701 on SPE2DB25FE4J8.
Is contract SPE2DB25FE4J8 an order under another contract?
Yes. SPE2DB25FE4J8 is a delivery order under SPE2DB20D1100, an indefinite delivery contract.
Was contract SPE2DB25FE4J8 competed?
The extent of competition for SPE2DB25FE4J8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award